Tango Therapeutics, Inc. (TNGX) — Stock Score Summary

Tango Therapeutics, Inc. (TNGX) has a MoatMap StockRank of 38/100 based on Quality (31/100), Value (34/100), and Momentum (59/100) factor scores. The current signal is HOLD.

Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing novel cancer therapies through its proprietary functional genomics and synthetic lethality drug discovery platform. The company aims to identify and target specific vulnerabilities in cancer cells, establishing a competitive moat through its innovative R&D approach and a pipeline of precision oncology drug candidates. Tango Therapeutics is an emerging player in the targeted cancer therapy landscape.

Key Financial Metrics

Price$20.00
Market Cap$2.9B
P/E (Forward)-12.60
Price/Book7.87
Return on Equity-38.4%
Return on Invested Capital-29.5%
Debt/Equity8.38
Gross Margin-126.8%
Operating Margin-206.2%
Free Cash Flow$-68M

Tango Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Tango Therapeutics, Inc.’s (TNGX) StockRank?
MoatMap’s StockRank for Tango Therapeutics, Inc. (TNGX) is 38/100, with a Hold signal. It is a composite of Quality (31), Value (34), and Momentum (59) factor ranks across MoatMap’s 19,000+ stock universe.
Does Tango Therapeutics, Inc. have an economic moat?
Tango Therapeutics, Inc. (TNGX) has a Quality factor score of 31/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Tango Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Tango Therapeutics, Inc. (TNGX) is Hold, based on a StockRank of 38/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Tango Therapeutics, Inc. in?
Tango Therapeutics, Inc. (TNGX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksTNGX deep dive reportAI ChampionsHow we score stocksSense-check another stock